MoonLake Immunotherapeutics's total assets for Q1 2026 were $400.37M, a decrease of -5.67% from the previous quarter. MLTX total liabilities were $146.35M for the fiscal quarter, a 22.01% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.